Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

NephroGenex Company Profile (NYSE:NRX)

Consensus Ratings for NephroGenex (NYSE:NRX) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.00 (167.74% upside)

Analysts' Ratings History for NephroGenex (NYSE:NRX)
Show:
DateFirmActionRatingPrice TargetActions
3/23/2015MLV & Co.Initiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/22/2013 forward)